BofA Securities Defending Regenxbio Inc. (RGNX), Shares Down 15pct
Tweet Send to a Friend
BofA Securities analyst Alec Stranahan reiterated a Buy rating and $22.00 price target on Regenxbio Inc. (NASDAQ: RGNX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
